Lord, Abbett & Co. LLC Karuna Therapeutics, Inc. Transaction History

Lord, Abbett & Co. LLC

$30.6 Billion
Q2 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 07, 2024	SELL	$164.66 - $218.08 $71.6 Million - $94.9 Million	-434,988 Reduced 75.7%	139,618 $23.6 Million
Q3 2023 Nov 13, 2023	SELL	$164.66 - $218.08 $71.6 Million - $94.9 Million	-434,988 Reduced 75.7%	139,618 $23.6 Million
Q2 2023 Oct 07, 2024	BUY	$176.32 - $240.22 $14.7 Million - $20 Million	83,464 Added 16.99%	574,606 $125 Million
Q2 2023 Aug 14, 2023	BUY	$176.32 - $240.22 $14.7 Million - $20 Million	83,464 Added 16.99%	574,606 $125 Million
Q1 2023 Oct 07, 2024	SELL	$161.33 - $204.36 $9.22 Million - $11.7 Million	-57,179 Reduced 10.43%	491,142 $89.2 Million
Q1 2023 May 12, 2023	SELL	$161.33 - $204.36 $9.22 Million - $11.7 Million	-57,179 Reduced 10.43%	491,142 $89.2 Million
Q4 2022 Oct 07, 2024	BUY	$191.53 - $236.82 $105 Million - $130 Million	548,321 New	548,321 $108 Million
Q4 2022 Feb 10, 2023	SELL	$191.53 - $236.82 $28.1 Million - $34.7 Million	-146,457 Reduced 21.08%	548,321 $108 Million
Q3 2022 Nov 14, 2022	BUY	$123.79 - $277.42 $51.1 Million - $114 Million	412,548 Added 146.17%	694,778 $156 Million
Q2 2022 Aug 12, 2022	SELL	$93.97 - $143.33 $8.2 Million - $12.5 Million	-87,315 Reduced 23.63%	282,230 $35.7 Million
Q1 2022 May 13, 2022	BUY	$98.9 - $132.37 $12.6 Million - $16.9 Million	127,840 Added 52.89%	369,545 $46.9 Million
Q4 2021 Feb 11, 2022	SELL	$110.64 - $159.4 $7.73 Million - $11.1 Million	-69,911 Reduced 22.43%	241,705 $31.7 Million
Q3 2021 Nov 09, 2021	SELL	$101.2 - $125.87 $5.77 Million - $7.18 Million	-57,030 Reduced 15.47%	311,616 $38.1 Million
Q2 2021 Aug 11, 2021	BUY	$107.45 - $135.95 $5.92 Million - $7.49 Million	55,085 Added 17.57%	368,646 $42 Million
Q1 2021 May 11, 2021	BUY	$95.46 - $133.08 $3.61 Million - $5.03 Million	37,834 Added 13.72%	313,561 $37.7 Million
Q4 2020 Feb 09, 2021	BUY	$75.23 - $109.23 $500,129 - $726,161	6,648 Added 2.47%	275,727 $28 Million
Q3 2020 Nov 12, 2020	BUY	$71.31 - $109.74 $537,320 - $826,890	7,535 Added 2.88%	269,079 $20.8 Million
Q2 2020 Aug 14, 2020	SELL	$62.14 - $117.21 $3.23 Million - $6.1 Million	-52,031 Reduced 16.59%	261,544 $29.2 Million
Q1 2020 May 14, 2020	BUY	$60.41 - $115.92 $7.29 Million - $14 Million	120,612 Added 62.51%	313,575 $22.6 Million
Q4 2019 Feb 14, 2020	BUY	$11.44 - $123.99 $2.21 Million - $23.9 Million	192,963 New	192,963 $14.5 Million

Others Institutions Holding KRTX

# of Institutions

Shares Held

332K

Call Options Held

Put Options Held

View Full List

About Karuna Therapeutics, Inc.

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

More about KRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lord, Abbett & Co. LLC with notifications on news.

Account